Evidence map›Paper›PMID 30899640›Full record

ArticleNanotheranostics2019

Nanomedicine-Assisted Combination Therapy of NSCLC: New Platinum-Based Anticancer Drug Synergizes the Therapeutic Efficacy of Ganetespib.

Jyothi Kallu, Tuhina Banerjee, Shoukath Sulthana, Saloni Darji, Ryan Higginbotham, Christina Fletcher, Nikolay N Gerasimchuk, Santimukul Santra

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanotheranostics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Revisiting Platinum-Based Anticancer Drugs to Overcome Gliomas.International journal of molecular sciences · 2021
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jyothi KalluDepartment of Chemistry, Pittsburg State University, 1701 S. Broadway Street, Pittsburg, Kansas 66762, United States.
Tuhina BanerjeeDepartment of Chemistry, Pittsburg State University, 1701 S. Broadway Street, Pittsburg, Kansas 66762, United States.
Shoukath SulthanaDepartment of Chemistry, Pittsburg State University, 1701 S. Broadway Street, Pittsburg, Kansas 66762, United States.
Saloni DarjiDepartment of Chemistry, Pittsburg State University, 1701 S. Broadway Street, Pittsburg, Kansas 66762, United States.
Ryan HigginbothamDepartment of Chemistry, Pittsburg State University, 1701 S. Broadway Street, Pittsburg, Kansas 66762, United States.
Christina FletcherDepartment of Chemistry, Pittsburg State University, 1701 S. Broadway Street, Pittsburg, Kansas 66762, United States.
Nikolay N GerasimchukDepartment of Chemistry, Missouri State University, 901 S. National Ave, Springfield, Missouri 65897, United States.
Santimukul SantraDepartment of Chemistry, Pittsburg State University, 1701 S. Broadway Street, Pittsburg, Kansas 66762, United States.
Pittsburg State University · US

Funding

Mentoring CoreP20GM103418 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Douglas E Wright · 2012 to 2026
$63.0M
"Magnetic Resonance Nanosensors for the Rapid Diagnosis of Influenza and Investigation of Viral Binding and Fusion Mechanisms"R03AI132832 · NIAID · PITTSBURG STATE UNIVERSITY · PI SANTRA, SANTIMUKUL · 2017 to 2018
$138k
NIAID NIH HHS R03 AI132832NIGMS NIH HHS P20 GM103418
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic Combined Chemotherapy ProtocolsCarcinoma, Non-Small-Cell LungLung NeoplasmsMagnetic FieldsMagnetite NanoparticlesNanomedicineA549 CellsAnimalsCHO CellsCricetulusHumansOrganoplatinum CompoundsProto-Oncogene Proteins p21(ras)TriazolesKRAS protein, humanMagnetite NanoparticlesOrganoplatinum CompoundsProto-Oncogene Proteins p21(ras)STA 9090TriazolesganetespibNon-Small-Cell Lung Cancerplatinum-based cyanoximate complex

Identifiers

PMID30899640
PMCPMC6427934
OpenAlexW2916261028

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.